Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 4-6, 2010, Pages 203-210

  Rock, Colleen ^a   Moos, Philip J ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

15 Hydroperoxyeicosatetraenoic acid; 15 Hydroxyeicosatetraenoic acid; Lipid hydroperoxidase; Selenoprotein P

Indexed keywords

15 HYDROPEROXYARACHIDONIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; LIPID HYDROPEROXIDE; SELENIUM; SELENOPROTEIN P;

ARTICLE; BIOENGINEERING; CELL ASSAY; CELL POPULATION; CELL PROTECTION; CELL STRAIN HEK293; CHRONIC INFLAMMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID OXIDATION; LIPOLYSIS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; TARGET CELL;

ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONIC ACID; CELLS, CULTURED; HUMANS; LEUKOTRIENES; LIPID PEROXIDES; SELENOPROTEIN P;

EID: 78649447529     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.08.006     Document Type: Article

References (61)

1. Itzkowitz S.H., Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G7-G17.
2. Macarthur M., Hold G.L., El-Omar E.M. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G515-G520.
3. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
4. Gupta S., Srivastava M., Ahmad N., Sakamoto K., Bostwick D.G., Mukhtar H. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 2001, 91:737-743.
5. Kelavkar U.P., Cohen C., Kamitani H., Eling T.E., Badr K.F. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis 2000, 21:1777-1787.
6. Kelavkar U.P., Nixon J.B., Cohen C., Dillehay D., Eling T.E., Badr K.F. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 2001, 22:1765-1773.
7. Hursting S.D., Thornquist M., Henderson M.M. Types of dietary fat and the incidence of cancer at five sites. Prev. Med. 1990, 19:242-253.
8. Natarajan R., Nadler J.L. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1542-1548.
9. Sordillo L.M., Streicher K.L., Mullarky I.K., Gandy J.C., Trigona W., Corl C.M. Selenium inhibits 15-hydroperoxyoctadecadienoic acid-induced intracellular adhesion molecule expression in aortic endothelial cells. Free Radical Biol. Med. 2008, 44:34-43.
10. Ray G., Husain S.A. Oxidants, antioxidants and carcinogenesis. Indian J. Exp. Biol. 2002, 40:1213-1232.
11. Yant L.J., Ran Q., Rao L., Van Remmen H., Shibatani T., Belter J.G., Motta L., Richardson A., Prolla T.A. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radical Biol. Med. 2003, 34:496-502.
12. Bjornstedt M., Hamberg M., Kumar S., Xue J., Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J. Biol. Chem. 1995, 270:11761-11764.
13. Mitsumoto A., Takanezawa Y., Okawa K., Iwamatsu A., Nakagawa Y. Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radical Biol. Med. 2001, 30:625-635.
14. Akesson B., Bellew T., Burk R.F. Purification of selenoprotein P from human plasma. Biochim. Biophys. Acta 1994, 1204:243-249.
15. Takahashi K., Cohen H.J. Selenium-dependent glutathione peroxidase protein and activity: immunological investigations on cellular and plasma enzymes. Blood 1986, 68:640-645.
16. Renko K., Werner M., Renner-Muller I., Cooper T.G., Yeung C.H., Hollenbach B., Scharpf M., Kohrle J., Schomburg L., Schweizer U. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem. J. 2008, 409:741-749.
17. Hill K.E., Zhou J., McMahan W.J., Motley A.K., Atkins J.F., Gesteland R.F., Burk R.F. Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 2003, 278:13640-13646.
18. Burk R.F., Hill K.E., Motley A.K., Austin L.M., Norsworthy B.K. Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole-body selenium content. Biochim. Biophys. Acta 2006, 1760:1789-1793.
19. Burk R.F., Hill K.E., Awad J.A., Morrow J.D., Kato T., Cockell K.A., Lyons P.R. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology 1995, 21:561-569.
20. Arteel G.E., Mostert V., Oubrahim H., Briviba K., Abel J., Sies H. Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol. Chem. 1998, 379:1201-1205.
21. Traulsen H., Steinbrenner H., Buchczyk D.P., Klotz L.O., Sies H. Selenoprotein P protects low-density lipoprotein against oxidation. Free Radical Res. 2004, 38:123-128.
22. Saito Y., Hayashi T., Tanaka A., Watanabe Y., Suzuki M., Saito E., Takahashi K. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human Selenoprotein P. J. Biol. Chem. 1999, 274:2866-2871.
23. Leist M., Raab B., Maurer S., Rosick U., Brigelius-Flohe R. Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity. Free Radical Biol. Med. 1996, 21:297-306.
24. Baker R.D., Baker S.S., Rao R. Selenium deficiency in tissue culture: implications for oxidative metabolism. J. Pediatr. Gastroenterol. Nutr. 1998, 27:387-392.
25. Saito Y., Yoshida Y., Akazawa T., Takahashi K., Niki E. Cell death caused by selenium deficiency and protective effect of antioxidants. J. Biol. Chem. 2003, 278:39428-39434.
26. Cordray P., Doyle K., Edes K., Moos P.J., Fitzpatrick F.A. Oxidation of 2-cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2. J. Biol. Chem. 2007, 282:32623-32629.
27. Yu M.K., Moos P.J., Cassidy P., Wade M., Fitzpatrick F.A. Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: modulation of selenoproteins by lipoxygenase enzymes. J. Biol. Chem. 2004, 279:28028-28035.
28. Takebe G., Yarimizu J., Saito Y., Hayashi T., Nakamura H., Yodoi J., Nagasawa S., Takahashi K. A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J. Biol. Chem. 2002, 277:41254-41258.
29. Rock C., Moos P.J. Selenoprotein P regulation by the glucocorticoid receptor. Biometals 2009, 22:995-1009.
30. Takahashi M., Shibata M., Niki E. Estimation of lipid peroxidation of live cells using a fluorescent probe, diphenyl-1-pyrenylphosphine. Free Radical Biol. Med. 2001, 31:164-174.
31. Burk R.F., Hill K.E. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 2005, 25:215-235.
32. Mostert V. Selenoprotein P: properties, functions, and regulation. Arch. Biochem. Biophys. 2000, 376:433-438.
33. Steinbrenner H., Alili L., Bilgic E., Sies H., Brenneisen P. Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radical Biol. Med. 2006, 40:1513-1523.
34. Steinbrenner H., Bilgic E., Alili L., Sies H., Brenneisen P. Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity. Free Radical Res. 2006, 40:936-943.
35. Angstwurm M.W., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., Abel P., Strauss R., Meier-Hellmann A., Insel R., Radke J., Schuttler J., Gartner R. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit. Care Med. 2007, 35:118-126.
36. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L., Park H.K., Sanders B.B., Smith C.L., Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study Group. J. Am. Med. Assoc. 1996, 276:1957-1963.
37. Mark S.D., Qiao Y.L., Dawsey S.M., Wu Y.P., Katki H., Gunter E.W., Fraumeni J.F., Blot W.J., Dong Z.W., Taylor P.R. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J. Natl. Cancer Inst. 2000, 92:1753-1763.
38. Nomura A.M., Lee J., Stemmermann G.N., Combs G.F. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2000, 9:883-887.
39. Brown K.M., Arthur J.R. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001, 4:593-599.
40. Angstwurm M.W., Gaertner R. Practicalities of selenium supplementation in critically ill patients. Curr. Opinion Clin. Nutr. Metab. Care 2006, 9:233-238.
41. Diwadkar-Navsariwala V., Diamond A.M. The link between selenium and chemoprevention: a case for selenoproteins. J. Nutr. 2004, 134:2899-2902.
42. Irons R., Carlson B.A., Hatfield D.L., Davis Both C.D. selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J. Nutr. 2006, 136:1311-1317.
43. Diwadkar-Navsariwala V., Prins G.S., Swanson S.M., Birch L.A., Ray V.H., Hedayat S., Lantvit D.L., Diamond A.M. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc. Natl. Acad. Sci. USA 2006, 103:8179-8184.
44. Tujebajeva R.M., Copeland P.R., Xu X.M., Carlson B.A., Harney J.W., Driscoll D.M., Hatfield D.L., Berry M.J. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 2000, 1:158-163.
45. Small-Howard A., Morozova N., Stoytcheva Z., Forry E.P., Mansell J.B., Harney J.W., Carlson B.A., Xu X.M., Hatfield D.L., Berry M.J. Supramolecular complexes mediate selenocysteine incorporation in vivo. Mol. Cell Biol. 2006, 26:2337-2346.
46. Howard M.T., Moyle M.W., Aggarwal G., Carlson B.A., Anderson C.B. A recoding element that stimulates decoding of UGA codons by Sec tRNA[Ser]Sec. RNA 2007, 13:912-920.
47. Bleys J., Navas-Acien A., Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch. Int. Med. 2008, 168:404-410.
48. Clark L.C., Hixson L.J., Combs G.F., Reid M.E., Turnbull B.W., Sampliner R.E. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol. Biomarkers Prev. 1993, 2:41-46.
49. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A., Parsons J.K., Bearden J.D., Crawford E.D., Goodman G.E., Claudio J., Winquist E., Cook E.D., Karp D.D., Walther P., Lieber M.M., Kristal A.R., Darke A.K., Arnold K.B., Ganz P.A., Santella R.M., Albanes D., Taylor P.R., Probstfield J.L., Jagpal T.J., Crowley J.J., Meyskens F.L., Baker L.H., Coltman C.A. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J. Am. Med. Assoc. 2009, 301:39-51.
50. Arthur J.R. The glutathione peroxidases. Cell. Mol. Life Sci. 2000, 57:1825-1835.
51. Steinbrenner H., Sies H. Protection against reactive oxygen species by selenoproteins. Biochim. Biophys. Acta 2009, 1790:1478-1485.
52. Ursini F., Maiorino M., Gregolin C. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim. Biophys. Acta 1985, 839:62-70.
53. Weaver J.A., Maddox J.F., Cao Y.Z., Mullarky I.K., Sordillo L.M. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. Free Radical Biol. Med. 2001, 30:299-308.
54. Kuhn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 2006, 45:334-356.
55. Seiler A., Schneider M., Forster H., Roth S., Wirth E.K., Culmsee C., Plesnila N., Kremmer E., Radmark O., Wurst W., Bornkamm G.W., Schweizer U., Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008, 8:237-248.
56. Kabuyama Y., Oshima K., Kitamura T., Homma M., Yamaki J., Munakata M., Homma Y. Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis. Genes Cells 2007, 12:1235-1244.
57. Nakayama A., Hill K.E., Austin L.M., Motley A.K., Burk R.F. All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium. J. Nutr. 2007, 137:690-693.
58. Yang J.G., Hill K.E., Burk R.F. Dietary selenium intake controls rat plasma selenoprotein P concentration. J. Nutr. 1989, 119:1010-1012.
59. Ochi H., Morita I., Murota S. Roles of glutathione and glutathione peroxidase in the protection against endothelial cell injury induced by 15-hydroperoxyeicosatetraenoic acid. Arch. Biochem. Biophys. 1992, 294:407-411.
60. Schnurr K., Belkner J., Ursini F., Schewe T., Kuhn H. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products. J. Biol. Chem. 1996, 271:4653-4658.
61. Huang H.S., Chen C.J., Suzuki H., Yamamoto S., Chang W.C. Inhibitory effect of phospholipid hydroperoxide glutathione peroxidase on the activity of lipoxygenases and cyclooxygenases. Prostaglandins Other Lipid Mediat. 1999, 58:65-75.